# Seismic Therapeutic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/seismic-therapeutic

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.seismictx.com
- Total disclosed funding: $183M
- Latest round: Series B (Nov 17, 2023)
- Investors on record: 11

## About

Based in Massachusetts, US, and founded in 2020 by Alan Crane, and Jo Viney (CEO), Seismic Therapeutic, Inc. operates as a biotechnology company that offers a platform of machine learning, structural biology, protein engineering, and translational immunology for immunology drug development, and antibody discovery. In December 2021, Seismic Therapeutic, Inc. raised USD 61.40 million in series A funding led by Lightspeed Venture Partners, with participation from Boxer Capital, GV, and Samsara BioCapital.

Seismic Therapeutic, Inc. is a creator of a biotechnology platform for advancing immunology drug development. Furthermore, the company addresses the central challenges of biologics discovery and drug development, with machine learning across the entire biologics discovery process, which enables drug developers to establish new, better, and faster ways to make medicines for patients.

The company plans to use the December 2021 funding to accelerate its pipeline of biologics targeting dysregulated adaptive immunity to treat autoimmune diseases.

## Funding rounds

- Series B, Nov 17, 2023, $121M — Lightspeed Venture Partners, Polaris Partners, Alexandria Venture Investments, Amgen Ventures, Bessemer Venture Partners, GV, GC&H Investments, Boxer Capital, Gaingels, Samsara BioCapital, Codon Capital
- Series A, Dec 21, 2021, $61M — Lightspeed Venture Partners, Polaris Partners, GV, Boxer Capital, Samsara BioCapital

## Investors

- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series A, Series B
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A, Series B
- GV (https://capitalatlas.ai/funds/gv) — Series A, Series B
- Boxer Capital (https://capitalatlas.ai/funds/boxer-capital) — Series A, Series B
- Samsara BioCapital (https://capitalatlas.ai/funds/samsara-biocapital) — Series A, Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series B
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series B
- GC&H Investments (https://capitalatlas.ai/funds/gc-h-investments) — Series B
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series B
- Codon Capital (https://capitalatlas.ai/funds/codon-capital) — Series B